TCRR - Tcr2 Therapeutics Inc
Close
1.48
-0.090 -6.081%
Share volume: 0
Last Updated: Wed 31 May 2023 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$1.57
-0.09
-5.73%
Summary score
30%
Profitability
25%
Dept financing
7%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.15%
Return on assets
-9.64%
Return on sales
0%
Return on invested capital
-1565.09%
Total debt ratio
4.46%
Debt ratio change over timeo
-1.02%
Current Ratio
22.73%
Quick Ratio
0%
Cash Position Ratio
8.34%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.27%
Return on assets
-10.26%
Return on sales
0%
Return on invested capital
-2338.4%
Total debt ratio
4.67%
Debt ratio change over timeo
-1.03%
Current Ratio
21.29%
Quick Ratio
0%
Cash Position Ratio
6.38%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-12.18%
Return on assets
-11.91%
Return on sales
0%
Return on invested capital
-6630.61%
Total debt ratio
4.96%
Debt ratio change over time
-1.05%
Current Ratio
21.03%
Quick Ratio
0%
Cash Position Ratio
7.81%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-96.2%
Return on assets
-95.51%
Return on sales
0%
Return on invested capital
1168.34%
Total debt ratio
-102.14%
Debt ratio change over time
-1.02%
Current Ratio
-10.65%
Quick Ratio
0%
Cash Position Ratio
-3.92%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TCRR | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -14.15% | -4.61% | -11.83% | 0% |
| Return on assets | -9.64% | -4.6% | -10.3% | 0% |
| Return on sales | 0% | -37.29% | 0% | 0% |
| Return on invested capital | -1565.09% | 265.33% | -27.14% | 0% |
| Profitability | 25% | 25% | 0% | 50% |
| Total debt ratio | 4.46% | 18.22% | 14.3% | 0% |
| Debt ratio change over time | -1.02% | -1.66% | -1.56% | 0% |
| Dept financing | 6% | 25% | 20% | 25% |
| Current Ratio | 21.29% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 6.38% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 32% | 12% | 0% |
| Short-term ratios | TCRR | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -10.27% | -3.62% | -13.55% | 0% |
| Return on assets | -10.26% | -3.93% | -11.56% | 0% |
| Return on sales | 0% | -34.27% | 0% | 0% |
| Return on invested capital | -2338.4% | -9.88% | -24.84% | 0% |
| Profitability | 25% | 0% | 0% | 75% |
| Total debt ratio | 4.67% | 15.47% | 15.89% | 0% |
| Debt ratio change over time | -1.03% | -0.59% | -1.72% | 0% |
| Dept financing | 7% | 24% | 25% | 25% |
| Current Ratio | 21.29% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 6.38% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 34% | 16% | 0% |